secondary hyperparathyroidism
Showing 1 - 25 of >10,000
d to Reveal Heterogeneity of Secondary Hyperparathyroidism
Not yet recruiting
- Secondary Hyperparathyroidism
- Single-cell sequencing
- (no location specified)
Nov 12, 2023
Secondary Hyperparathyroidism Trial (SHR6508, Cinacalcet)
Not yet recruiting
- Secondary Hyperparathyroidism
- (no location specified)
Dec 21, 2022
Efficacy and Safety of Pacitol Inj.
Recruiting
- Chronic Kidney Disease 5D
- Secondary Hyperparathyroidism
-
Goyang-si, Gyeonggi-do, Korea, Republic ofDongGuk university Ilsan hospital
Nov 6, 2023
Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- PLS240
- +2 more
- (no location specified)
Apr 17, 2023
3T MR for Secondary Hyperparathyroidism Comparison With 4DCT
Not yet recruiting
- Parathyroid Gland Disease
- Secondary Hyperparathyroidism
- (no location specified)
Sep 15, 2022
Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- End Stage Kidney Disease
- PLS240
- +2 more
- (no location specified)
Apr 18, 2023
Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency Trial (CTAP101, Placebo)
Not yet recruiting
- Chronic Kidney Disease stage3
- +3 more
- CTAP101
- Placebo
- (no location specified)
Sep 13, 2022
Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Deficiency, CKD Stage 3 Trial in Garden Grove, Chicago, West Bend
Completed
- Secondary Hyperparathyroidism Due to Renal Causes
- +3 more
- Calcifediol Oral Capsule
- +3 more
-
Garden Grove, California
- +2 more
Nov 14, 2022
Precision Medicine Approaches to Renal Osteodystrophy
Recruiting
- Renal Osteodystrophy
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
May 28, 2023
Secondary Hyperparathyroidism Trial (SHR6508;Placebo)
Not yet recruiting
- Secondary Hyperparathyroidism
- SHR6508；Placebo
- (no location specified)
Jan 20, 2022
Secondary Hyperparathyroidism Trial in Baltimore (Teriparatide)
Completed
- Secondary Hyperparathyroidism
-
Baltimore, MarylandUniversity of Maryland School of Medicine Division of Endocrinol
Mar 30, 2022
Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis Trial in Saint Petersburg
Completed
- Secondary Hyperparathyroidism
- +4 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University Hospital
Nov 7, 2022
Secondary Hyperparathyroidism Trial (Paricalcitol, Placebo)
Not yet recruiting
- Secondary Hyperparathyroidism
- Paricalcitol
- Placebo
- (no location specified)
Jan 27, 2022
Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)
Completed
- Sodium Zirconium Cyclosilicate
- +2 more
- Sodium zirconium cyclosilicate
- (no location specified)
May 16, 2022
Chronic Kidney Disease 5D, Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Deficiency Trial (High-dose vitamin D2
Recruiting
- Chronic Kidney Disease 5D
- +2 more
- High-dose vitamin D2 softgels
- +2 more
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi 'an Jiaotong University
Jan 5, 2023
Secondary Hyperparathyroidism;Parathyroidectomy Trial in Nanjing (Parathyroidectomy)
Recruiting
- Secondary Hyperparathyroidism;Parathyroidectomy
- Parathyroidectomy
-
Nanjing, ChinaNanjingMU
Sep 23, 2021
Parathyroidectomy on Cardiovascular Calcification in
Active, not recruiting
- Secondary Hyperparathyroidism
- +3 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University, Clinic of advanced medical te
Nov 2, 2022
(NIS) on Effectiveness in ND-CKD SHPT Patients
Not yet recruiting
- Chronic Kidney Disease
- (no location specified)
Jul 12, 2022
Secondary Hyperparathyroidism Trial in Worldwide (KHK7580, Cinacalcet Hydrochloride)
Completed
- Secondary Hyperparathyroidism
- KHK7580
- Cinacalcet Hydrochloride
-
Changsha, China
- +33 more
Apr 21, 2022
Kidney Failure, Secondary Hyperparathyroidism, Vascular Diseases Trial in Hong Kong (Cinacalcet, Surgical total
Completed
- Kidney Failure
- +2 more
- Cinacalcet
- Surgical total parathyroidectomy with forearm autografting
-
Hong Kong, Hong KongQueen Mary Hospital and Tung Wah Hospital
Oct 4, 2021
Secondary Hyperparathyroidism-Chronic Kidney Disease Trial in Chile, United States (Doxercalciferol (GZ427397), Calcitriol)
Active, not recruiting
- Secondary Hyperparathyroidism-Chronic Kidney Disease
- Doxercalciferol (GZ427397)
- Calcitriol
-
Birmingham, Alabama
- +29 more
May 3, 2022
Hyperparathyroidism, Secondary Trial in Sao Paulo (Subtotal Parathyroidectomy, Total Parathyroidectomy + 45 autografts, Total
Active, not recruiting
- Hyperparathyroidism, Secondary
- Subtotal Parathyroidectomy
- +2 more
-
Sao Paulo, SP, BrazilUniversity of Sao Paulo General Hospital
May 23, 2022
Secondary Hyperparathyroidism, Hypercalcemia Trial in Bronx (Cinacalcet HCl)
Terminated
- Secondary Hyperparathyroidism
- Hypercalcemia
- Cinacalcet HCl
-
Bronx, New YorkMontefiore Medical Center
Apr 22, 2021
Postmenopausal Osteoporosis, Postmenopause, Hyperparathyroidism, Secondary Trial in Mexico City (Cholecalciferol)
Completed
- Postmenopausal Osteoporosis
- +4 more
-
Mexico City, MexicoPeri-postmenopause and bone metabolism clinic. Regional Hospital
Apr 30, 2022